Diabetes and aspirin: beware of underpowered negative trials.
Farkouh
Michael E
ME
Fuster
Valentin
V
D001241:Aspirin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods*; D048909:Diabetes Complications / Q000517:prevention & control*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control*; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D018401:Sample Size; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D001241:Aspirin